Patrick Legembre, the self-investigator
French cancer researcher Patrick Legembre works on cell death, but his datasets come alive as zombies of varying cell types. So Legembre investigates!
Category: Research integrity
Real rats tortured for fake neuroscience
Smut Clyde complained of his eyes hurting from all these repetitive patterns in neuron recordings. He now recovered, and wrote this report, about rat torturers of Michigan.
Carlos Lopez-Otin and the revoked Nature Mentoring Award
St Carlos of Oviedo almost was canonised as Spain’s first living martyr, but now Nature revoked his mentoring award. Spanish media and science elites are desperate, even the Queen is not amused.
From Russia, with Photoshop
Germany recruits the very best of the best in international science to its elite institutions. Professor Alexandr Bazhin is one of them.
Gaetano Cairo’s doped science
Smut Clyde is back to Milan, to show you some more artworks exhibited at the Institute of General Pathology. He will give you a quick run of Gaetano Cairo’s doped science.
Alfonsina Desiderio and her pathological Bully Boys
Smut Clyde and Clare Francis studied the works of Milanese cancer researchers around Maria Alfonsina Desiderio. There are even ideas for T-shirts!
Misconduct findings fell KI Vice-President Dahlman-Wright
Karolinska Vice-president Karin Dahlman-Wright was found guilty of research misconduct, not much, only in one case, and even that shared. But she already resigned.
David Latchman, uncensored
I publish exclusively two uncensored UCL screening panel reports into the David Latchman and Anastasis Stephanou affair. Now we know which papers were investigated and which requested retractions didn’t happen.
Carrots and sticks for fraudsters at Royal Society of Chemistry
Smut Clyde goes nanotechnology again and disagrees with Royal Society of Chemistry and the Chinese authorities on how honest a researcher Mi-Cong Jin is.
Sanofi R&D Head John Reed knows how to science
In 2018, the pharma giant Sanofi appointed with John Reed a new R&D head. Apparently Sanofi does not believe in PubPeer.
